Core Laboratories

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$130,577
$129,637
$128,210
$125,343
Gross Profit
23,877
21,206
22,819
24,797
EBITDA
17,388
13,260
18,028
19,610
EBIT
13,618
9,417
14,154
15,681
Net Income
9,032
3,220
6,462
9,257
Net Change In Cash
130,577
129,637
128,210
125,343
Free Cash Flow
14,213
2,475
16,634
-3,692
Cash
17,695
14,913
15,119
16,616
Basic Shares
47,743
47,703
47,557
47,604

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$509,789
$489,735
$470,252
$487,267
Gross Profit
94,049
78,919
83,840
91,633
EBITDA
69,574
58,685
63,778
76,641
EBIT
53,790
41,524
45,262
55,774
Net Income
36,675
19,453
19,727
-97,073
Net Change In Cash
509,789
489,735
470,252
487,267
Cost of Revenue
-2,275
3,897
2,714
Free Cash Flow
14,210
14,740
23,040
45,988
Cash
15,119
15,428
17,703
13,806
Basic Shares
47,523
46,813
46,690
44,974

Earnings Calls

Quarter EPS
2024-06-30
$0.22
2024-03-31
$0.19
2023-12-31
$0.19
2023-09-30
$0.22